Cargando…
Heart failure with reduced ejection fraction and the intersection of cardio-renal-metabolic medicine #CaReMe
Diabetes and chronic kidney disease (CKD) are important comorbidities in patients with heart failure (HF) that can complicate the clinical management and have major implications for morbidity and mortality. In addition, the presence of these comorbidities, particularly advanced CKD, is a limitation...
Autores principales: | Marx, Nikolaus, Cheng, Alice Y Y, Agarwal, Rajiv, Greene, Stephen J, Abuhantash, Hadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762887/ https://www.ncbi.nlm.nih.gov/pubmed/36545231 http://dx.doi.org/10.1093/eurheartjsupp/suac114 |
Ejemplares similares
-
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?
por: Docherty, Kieran F, et al.
Publicado: (2022) -
Dear colleagues: enough with the men-only author panels
por: Van Spall, Harriette G C, et al.
Publicado: (2022) -
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
por: Tomasoni, Daniela, et al.
Publicado: (2022) -
Time for change
por: Zieroth, Shelley, et al.
Publicado: (2022) -
Representation matters: a call for inclusivity and equity in heart failure clinical trials
por: Reza, Nosheen, et al.
Publicado: (2022)